(d).
Top networks | ||
---|---|---|
ID | Associated network functions | Score |
(1) | Nucleic acid metabolism, small molecule biochemistry, cell signaling | 42 |
(2) | Auditory disease, cancer, cardiovascular disease | 42 |
(3) | Carbohydrate metabolism, drug metabolism, small molecule biochemistry | 37 |
(4) | Cellular growth and proliferation, tissue development, cellular movement | 37 |
(5) | Embryonic development, humoral immune response, lymphoid tissue structure and development | 33 |
This is a comprehensive list of the top canonical pathways and top upstream regulators with predicted differential regulation as well as diseases, biofunctions, and networks with the highest enrichment involving significant genes identified in our dataset based on p values and other criteria set by IPA. Amongst the top canonical pathways, Hippo signaling has the highest overlap in genes from our dataset that are enriched in the pathway divided by the total number of genes enriched in the Hippo pathway, that is, 8.1% according to the current IPA database. NS-398 which is a cyclooxygenase inhibitor is amongst the top upstream regulator with a p value of 5.54E − 05. The top diseases associated with citalopram treatment include cancer with 511 molecules predicted to have differential regulation, whereas the top physiological system development and function predicted to be effected includes nervous system development and function with 107 molecules identified by IPA. The top associated gene network functions include nucleic acid metabolism, small molecule biochemistry, and cell signaling with a score of 42 generated by the IPA algorithm. A score of 50 is considered as high and below 20 is low. Predicted activation.